ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Reneo Pharmaceuticals Inc

Reneo Pharmaceuticals Inc (RPHM)

1.48
0.01
(0.68%)
Closed July 21 4:00PM
1.49
0.01
(0.68%)
After Hours: 7:59PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.48
Bid
1.25
Ask
1.54
Volume
77,001
1.48 Day's Range 1.52
0.9801 52 Week Range 9.21
Market Cap
Previous Close
1.47
Open
1.49
Last Trade
595
@
1.48
Last Trade Time
Financial Volume
$ 114,691
VWAP
1.4895
Average Volume (3m)
286,529
Shares Outstanding
33,420,808
Dividend Yield
-
PE Ratio
-0.64
Earnings Per Share (EPS)
-2.32
Revenue
-
Net Profit
-77.39M

About Reneo Pharmaceuticals Inc

Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Reneo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPHM. The last closing price for Reneo Pharmaceuticals was $1.47. Over the last year, Reneo Pharmaceuticals shares have traded in a share price range of $ 0.9801 to $ 9.21.

Reneo Pharmaceuticals currently has 33,420,808 shares outstanding. The market capitalization of Reneo Pharmaceuticals is $49.13 million. Reneo Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.64.

RPHM Latest News

Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law Firm

Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law Firm PR Newswire NEW YORK, July 1, 2024 NEW YORK, July 1, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKureโ€™s portfolio of novel precision medicines in oncology Combined company is expected to have...

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

IRVINE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies...

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies...

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors

SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.03-1.986754966891.511.561.47505541.494798CS
4-0.1-6.329113924051.581.651.461862971.52257219CS
12-0.18-10.8433734941.661.931.422865291.61461943CS
26-0.15-9.202453987731.631.931.322534801.63291226CS
52-5.29-78.13884785826.779.210.98014193612.5051462CS
156-7.14-82.83062645018.6211.39990.98011859023.32924581CS
260-13.82-90.326797385615.316.830.98011784453.70663778CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
AUGXAugmedix Inc
$ 2.27
(147.71%)
24.14M
XCURExicure Inc
$ 0.5351
(76.02%)
14.02M
PSNLPersonalis Inc
$ 3.83
(56.33%)
22.8M
MDBHMDB Capital Holdings LLC
$ 10.675
(37.21%)
126.45k
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M
HYZNHyzon Motors Inc
$ 0.149
(-47.54%)
23.63M
MEDSTRxADE Health Inc
$ 14.92
(-33.45%)
223.27k
SILOSilo Pharma Inc
$ 2.50
(-27.95%)
11.93M
KITTNauticus Robotics Inc
$ 0.0935
(-27.46%)
28.43M
SERVServe Robotics Inc
$ 7.51
(185.55%)
262.73M
NVDANVIDIA Corporation
$ 117.93
(-2.61%)
206.41M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.2602
(5.77%)
202.14M
SQQQProShares UltraPro Short QQQ
$ 8.46
(2.79%)
184.21M
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
119.98M

Your Recent History

Delayed Upgrade Clock